Skip to main content

Lobbying activity

Who's lobbying Congress, for whom, and on what — from federal Lobbying Disclosure Act filings. Covers both chambers, synced daily. 1,778 filings

Top spenders & firms Spend by issue

Clear
RR
MARSHALL & POPP, LLC for GLAXOSMITHKLINE
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia
Pharmacy, Trade (domestic/foreign)
View →
1A
ALSTON & BIRD LLP for TRAVERE THERAPEUTICS
1st Quarter (Jan 1 - Mar 31) 2025 · California · House · Senate · $60,000.00 income
Medical/Disease Research/Clinical Labs, Health Issues, Medicare/Medicaid, Pharmacy
View →
RR
CORCORAN & ASSOCIATES, INC. DBA CORCORAN PARTNERS for KYOWA KIRIN, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey
Economics/Economic Development, Government Issues, Health Issues, Medicare/Medicaid
View →
4A
KAISER FOUNDATION HEALTH PLAN INC. for KAISER FOUNDATION HEALTH PLAN INC
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · Senate
Health Issues, Medicare/Medicaid, Taxation/Internal Revenue Code, Defense
View →
RR
MARSHALL & POPP, LLC for DAIICHI SANKYO, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey
Pharmacy, Trade (domestic/foreign)
View →
RR
CHECKMATE GOVERNMENT RELATIONS for BIOHAVEN LTD.
1st Quarter (Jan 1 - Mar 31) 2026 · Connecticut
Health Issues, Medical/Disease Research/Clinical Labs, Pharmacy
View →
RR
MARSHALL & POPP, LLC for BRISTOL-MYERS SQUIBB COMPANY
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey
Pharmacy, Trade (domestic/foreign)
View →
RR
MARSHALL & POPP, LLC for SUN PHARMACEUTICAL INDUSTRIES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New Jersey
Pharmacy, Trade (domestic/foreign)
View →
4A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
3A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
2A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
2nd Quarter (Apr 1 - June 30) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
1A
PENN AVENUE PARTNERS for UNITEDHEALTH GROUP, INC.
1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $90,000.00 income
Health Issues, Medicare/Medicaid, Pharmacy
View →
RR
THE WAYFINDER GROUP for YC CONSULTING, LLC ON BEHALF OF DISPOSE RX, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia
Health Issues, Pharmacy
View →
Q4
THE HEALTH EQUITY STRATEGIES GROUP, LLC for TRAVERE THERAPEUTICS
4th Quarter (Oct 1 - Dec 31) 2025 · California · House · $16,000.00 income
Health Issues, Medical/Disease Research/Clinical Labs, Medicare/Medicaid, Pharmacy
View →
RR
K&L GATES, LLP for BORYUNG CORPORATION
1st Quarter (Jan 1 - Mar 31) 2026
Aerospace, Pharmacy, Science/Technology
View →
Q4
MR. DAN CRIPPEN for AMGEN
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $100,000.00 income
Pharmacy, Economics/Economic Development, Government Issues
View →
Q4
RAY ANDERSON for 340B HEALTH
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House
Pharmacy, Health Issues, Medicare/Medicaid
View →
Q4
H. LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE for H LEE MOFFITT CANCER CENTER & RESEARCH INSTITUTE
4th Quarter (Oct 1 - Dec 31) 2025 · Florida · House · Senate
Health Issues, Budget/Appropriations, Economics/Economic Development, Pharmacy
View →
RR
JEFFREY J. KIMBELL & ASSOCIATES, INC. for ORCHARD THERAPEUTICS NORTH AMERICA
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts
Pharmacy, Medicare/Medicaid, Health Issues
View →
RR
CROSSROADS STRATEGIES, LLC for BLINK HEALTH, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · New York
Pharmacy
View →
RA
CROSSROADS STRATEGIES, LLC for ALKERMES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts
Pharmacy
View →
Q4
POWERS PYLES SUTTER & VERVILLE, P.C. for NATIONAL ASSOCIATION OF SPECIALTY PHARMACY
4th Quarter (Oct 1 - Dec 31) 2025 · District of Columbia · House · Senate · $120,000.00 income
Medicare/Medicaid, Pharmacy, Health Issues
View →
Q4
ACADEMY OF MANAGED CARE PHARMACY for ACADEMY OF MANAGED CARE PHARMACY
4th Quarter (Oct 1 - Dec 31) 2025 · Virginia · House · Senate
Pharmacy, Medicare/Medicaid
View →
RR
VENABLE LLP for STRIVE SPECIALTIES, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Arizona
Pharmacy
View →
RR
SONORAN POLICY GROUP, LLC D/B/A STRYK GLOBAL DIPLOMACY, FORMERLY KNOWN AS SONORA for COLLEGIUM PHARMACEUTICAL, INC.
1st Quarter (Jan 1 - Mar 31) 2026 · Massachusetts
Pharmacy
View →
Previous Page 16 of 72 Next

Source: federal Lobbying Disclosure Act filings. A filing's bill references are parsed from its activity descriptions, so a bill page shows the filings that named it.

Report a problem